PHARMACOKINETICS OF THE NEW HEPATITIS C VIRUS NS3 PROTEASE INHIBITOR NARLAPREVIR FOLLOWING SINGLE-DOSE USE WITH OR WITHOUT RITONAVIR IN PATIENTS WITH LIVER CIRRHOSIS ArticleIsakov V., Koloda D., Tikhonova N., Krasavina E., Samsonov M., Kikalishvili T., Lekishvili K., Malaya I., Ryska M., Tolkacheva V.Antimicrobial Agents and Chemotherapy. Vol. 60. 2016.
NEW APPROACH FOR ASSESSMENT OF LEFT VENTRICULAR HYPERTROPHY REGRESSION ArticleKotovskaya Y., Malaya I., Kobalava Z.Journal of Hypertension. Vol. 26. 2008.
CHANGES OF LEFT VENTRICULAR MYOCARDIAL MASS INDEX, QT INTERVAL AND QT DISPERSION IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY DURING LONG-TERM ANTIHYPERTENSIVE TREATMENT ArticleEfimova V., Malaya I., Tulkina E.Journal of Hypertension. Vol. 25. 2007.
PREDICTORS OF REGRESSION AND PERSISTENCE LEFT VENTRICULAR HYPERTROPHY DURING LONG TERM ANTIHYPERTENSIVE TREATMENT ArticleEfimova V., Bulkina O., Malaya I., Milto A.Journal of Hypertension. Vol. 25. 2007.
GENETIC PREDICTORS OF LEFT VENTRICULAR MASS CHANGES DURING LONG TERM ANTIHYPERTENSIVE TREATMENT ArticleMalaya I., Moiseev V., Kobalava Z.Journal of Hypertension. Vol. 25. 2007.